{
    "ticker": "BTRN",
    "name": "Biotricity, Inc.",
    "description": "Biotricity, Inc. is a leading developer of innovative biometric monitoring solutions aimed at improving patient care and enhancing the efficiency of healthcare delivery. Founded in 2016, the company specializes in advanced cardiac monitoring and telehealth technologies that empower patients and healthcare providers alike. Biotricity's flagship product, the Bioflux, is a revolutionary cardiac monitoring device that offers real-time data transmission and analysis, allowing for timely interventions and improved outcomes for patients with cardiovascular conditions. The company is dedicated to advancing the field of remote patient monitoring through its proprietary algorithms and machine learning capabilities, which enable healthcare providers to track patients' health metrics seamlessly. Biotricity's mission is to transform the way healthcare is delivered by integrating state-of-the-art technology with patient-centered care, ensuring that patients receive accurate and timely medical attention. With a focus on innovation, quality, and compliance, Biotricity is poised to play a pivotal role in the future of healthcare technology.",
    "industry": [
        "Health Technology",
        "Medical Devices"
    ],
    "headquarters": "San Francisco, California, USA",
    "founded": "2016",
    "website": "https://www.biotricity.com",
    "ceo": "W. John McCarthy",
    "social_media": {
        "twitter": "https://twitter.com/Biotricity",
        "linkedin": "https://www.linkedin.com/company/biotricity"
    },
    "investor_relations": "https://www.biotricity.com/investors",
    "key_executives": [
        {
            "name": "W. John McCarthy",
            "position": "CEO"
        },
        {
            "name": "Drew D. W. Haines",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Cardiac Monitoring Devices",
            "products": [
                "Bioflux"
            ]
        },
        {
            "category": "Telehealth Solutions",
            "products": [
                "Remote Patient Monitoring"
            ]
        }
    ],
    "seo": {
        "meta_title": "Biotricity, Inc. | Innovating Healthcare Technology",
        "meta_description": "Explore Biotricity, Inc., a leader in biometric monitoring and telehealth solutions. Discover our commitment to improving patient outcomes and healthcare delivery.",
        "keywords": [
            "Biotricity",
            "Healthcare Technology",
            "Cardiac Monitoring",
            "Telehealth",
            "Remote Patient Monitoring"
        ]
    },
    "faq": [
        {
            "question": "What does Biotricity specialize in?",
            "answer": "Biotricity specializes in biometric monitoring solutions and telehealth technologies for better patient care."
        },
        {
            "question": "Who is the CEO of Biotricity?",
            "answer": "W. John McCarthy is the CEO of Biotricity, Inc."
        },
        {
            "question": "Where is Biotricity headquartered?",
            "answer": "Biotricity is headquartered in San Francisco, California, USA."
        },
        {
            "question": "What is the main product of Biotricity?",
            "answer": "The main product of Biotricity is the Bioflux, an advanced cardiac monitoring device."
        },
        {
            "question": "When was Biotricity founded?",
            "answer": "Biotricity was founded in 2016."
        }
    ],
    "competitors": [
        "MDGS",
        "AVAH",
        "ABT"
    ],
    "related_stocks": [
        "AAPL",
        "AMZN",
        "GOOGL",
        "MSFT"
    ]
}